The store will not work correctly when cookies are disabled.
2-Hydroxyethyl 1-(2-(4-isobutylphenyl)propanoyl)pyrrolidine-2-carboxylate
ID: ALA2262183
PubChem CID: 76330284
Max Phase: Preclinical
Molecular Formula: C20H29NO4
Molecular Weight: 347.46
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)Cc1ccc(C(C)C(=O)N2CCCC2C(=O)OCCO)cc1
Standard InChI: InChI=1S/C20H29NO4/c1-14(2)13-16-6-8-17(9-7-16)15(3)19(23)21-10-4-5-18(21)20(24)25-12-11-22/h6-9,14-15,18,22H,4-5,10-13H2,1-3H3
Standard InChI Key: UEEWWZTXTMHYOK-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 26 0 0 0 0 0 0 0 0999 V2000
18.1387 -26.2661 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4713 -25.7812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7262 -24.9966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5512 -24.9966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8062 -25.7812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6867 -26.0362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0736 -25.4841 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.5576 -26.8510 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.1387 -27.0911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8532 -27.5036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8532 -28.3286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4243 -27.5036 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.5677 -27.0911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5677 -26.2661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2822 -25.8536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9966 -26.2661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9966 -27.0911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2822 -27.5036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7111 -25.8536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4256 -26.2661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1400 -25.8536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4256 -27.0911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7874 -27.1467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6584 -27.9615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8882 -28.2572 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
1 5 1 0
6 7 2 0
6 8 1 0
2 6 1 0
9 10 1 0
10 11 1 0
9 12 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
13 18 2 0
19 20 1 0
20 21 1 0
20 22 1 0
16 19 1 0
10 13 1 0
1 9 1 0
23 24 1 0
24 25 1 0
8 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 347.46 | Molecular Weight (Monoisotopic): 347.2097 | AlogP: 2.52 | #Rotatable Bonds: 7 |
Polar Surface Area: 66.84 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.04 | CX LogD: 3.04 |
Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.77 | Np Likeness Score: -0.31 |
References
1. Doulgkeris CM, Siskou IC, Xanthopoulou N, Lagouri V, Kravaritou C, Eleftheriou P, Kourounakis PN, Rekka EA. (2012) Compounds against inflammation and oxidative insult as potential agents for neurodegenerative disorders, 21 (9): [10.1007/s00044-011-9726-x] |